Ordenar

Buscar

01/07/2026 Walking Recovery After Hip Fracture in Patients with Exceptional Longevity: Predictors and Association with Short- and Long-Term Survival
Barceló, M, Marquez, PV, Gich, I, Casademont, J, Torres, OH. Walking Recovery After Hip Fracture in Patients with Exceptional Longevity: Predictors and Association with Short- and Long-Term Survival. Journal of Clinical Medicine. 2026; 15(13)DOI:10.3390/jcm15135085. PMID:42452546. IF:2.900(Q1/2D).
01/07/2026 Abatacept versus hydroxychloroquine for prevention of rheumatoid arthritis in individuals with palindromic rheumatism: a randomized open-label trial
Sanmarti, R, Pérez-García, C, de-Toro, FJ, Salvador, G, Escudero-Contreras, A, Cuervo, A, Graell, E, Reina, D, Kanterewicz, E, Corominas, H, Urionaguena-Onaindia, I, López-Lasanta, M, Olivé, A, Sala-Gómez, M, Frade-Sosa, B, Morlà-Novell, RM, Polino, L, Meraz-Ostiz, JA, Oreiro, N, Blanco, FJ, Pérez-Nadales, I, Ortega-Castro, R, Busquets-Pérez, N, Gómez-Centeno, AD, Camacho, O, Rodríguez-Cros, JR, Millan-Arciniegas, AM, García-Llorente, JF, Borrell, H, Prior-Español, A, Castell-Quiñones, S, Cruceta, A, Bonfill, E, Domenech-Gómez, G, Roca-Fàbregas, A, Ríos, J, Tobalina-Maestre, L, Gómara, MJ, Haro, I. Abatacept versus hydroxychloroquine for prevention of rheumatoid arthritis in individuals with palindromic rheumatism: a randomized open-label trial. NATURE MEDICINE. 2026; 32(7)DOI:10.1038/s41591-026-04395-6. PMID:42135532. IF:50.000(Q1/1D).
01/07/2026 How DNA methylation predicts response to cancer therapies
Davalos, V, Ferrer, G, Esteller, M. How DNA methylation predicts response to cancer therapies. Trends in Cancer. 2026; 12(7)DOI:10.1016/j.trecan.2026.04.002. PMID:42086381. IF:17.500(Q1/1D).
01/07/2026 Naming performance in bilinguals with Alzheimer's disease and mild cognitive impairment
Sainz-Pardo, M, Hernández, M, Suades, A, Juncadella, M, Ortiz-Gil, J, Ugas, L, Sala, I, Lleó, A, Calabria, M. Naming performance in bilinguals with Alzheimer's disease and mild cognitive impairment. JOURNAL OF ALZHEIMERS DISEASE. 2026; 112(2)DOI:10.1177/13872877261452694. PMID:42227174. IF:3.100(Q2/5D).